Lifeboat Foundation

A new episode of our podcast, “Show Me the Science,” has been posted. These episodes feature stories about groundbreaking research, as well as lifesaving and just plain cool stuff involving faculty, staff and students at Washington University School of Medicine in St. Louis.

In this episode, Washington University researchers discuss the Food and Drug Administration’s recent full approval of the drug Leqembi (lecanemab) and what it could mean to the future of Alzheimer’s disease treatments. The drug is approved for use in people with mild dementia from Alzheimer’s disease, but researchers at Washington University’s Charles F. and Joanne Knight Alzheimer Disease Research Center (ADRC), believe the drug, along with other medications in clinical trials, one day may help prevent the development of memory loss and problems with thinking in people who have Alzheimer’s pathology in the brain but who have not yet developed clinical symptoms of the disease.

Barbara Joy Snider, MD, PhD, a professor of neurology and director of clinical trials at the Knight ADRC, says that although Leqembi doesn’t cure Alzheimer’s disease, it slows the decline in memory and thinking, and it also slows the progression of the disorder by removing some amyloid plaques from the brain.

Even when a bone marrow transplant cures leukemia or lymphoma, GVHD—in which T cells in the donor graft attack the recipient’s own tissues—can still be fatal. The condition is among the leading causes of death and long-term adverse health consequences associated with bone marrow transplants.

Senior co-corresponding authors Ivan Maillard, MD, PhD, a professor of Medicine and vice chief for research in Hematology-Oncology at the Perelman School of Medicine at the University of Pennsylvania, and Leslie S. Kean, MD, PhD, a professor of Pediatrics at Harvard Medical School and director of Pediatric Stem Cell Transplant at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, along with… More.

In new preclinical research, an experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease in the intestines, without causing broad immune suppression, paving the way for clinical trials.

Continue reading “Antibody Prevents Graft Versus Host Disease in Preclinical Tests” »

Digesting a crunchy critter starts with the audible grinding of its rigid protective covering — the exoskeleton. Unpalatable as it may sound, the hard cover might be good for the metabolism, according to a new study, in mice, from Washington University School of Medicine in St. Louis. The researchers, led by Steven Van Dyken, PhD, an assistant professor of pathology & immunology, found in mice that digesting chitin, an abundant dietary fiber in insect exoskeletons and also mushrooms and crustacean shells, engages the immune system. An active immune response was linked to less weight gain, reduced body fat and a resistance to obesity. “Obesity is an epidemic,” Van Dyken said. “What we put into our bodies has a profound effect on our physiology and on how we metabolize food. We’re investigating ways to counteract obesity based on what we learn about how the immune system is engaged by diet.”

Findings, in mice, suggest engaging immune system with such fiber to counteract obesity.

Join us as we explore the intersection of AI and Quantum Computing, at the forefront of tech advancements. 🤖

Want to support our production? Feel free to join our membership at https://www.youtube.com/BeeyondIdeas/join.

Continue reading “‘The Next Computing Revolution is with AI-Quantum’ ft. Michio Kaku” »

Chandrayaan-3 rover confirms presence of sulphur in lunar surface, search for Hydrogen underway: ISRO.

China Mobile on Saturday launched the largest quantum cloud computing platform in China along with China Electronics Technology Group Corp (CETGC), vowing to take quantum computing to a new level of practical use.

As the country’s most recent computing platform, it achieved hybrid computing of both quantum and general computing power for the first time in the industry, China Mobile said in a statement.

The platform was unveiled at the 2023 China Computational Conference in Yinchuan, Northwest China’s Ningxia Hui Autonomous Region.

Continue reading “China introduces largest quantum cloud computing platform” »

What once was thought to be a Science fiction is now fact which means mind uploading is just around the corner 🤔.

Back in 2018, scientists achieved something that still sounds unbelievable today: they “transplanted” memories from one snail into another. It was a fascinating study in its own right, but it’s also part of a much bigger story: the long-running human quest to understand precisely what memory is and how it works.

How the study worked

Continue reading “How Scientists Managed To Transfer ‘Memories’ Between Snails” »

Our guest contributor for today’s blog is Amy Boyle, Director of Commercial and Advisory Partner Enablement.

As Microsoft and our partners find innovative ways to push the capabilities of advanced technologies, the need for IT employees with updated skills remains. Organizations across the industry are having difficulty finding employees with expertise on the latest platforms.

During this year’s Microsoft Inspire event, leaders from our partners TCS and Kyndryl talked about how training employees is fueling growth within their companies and the industry as a whole. Working together, Microsoft, TCS, and Kyndryl are making skills development on Microsoft Cloud and other platforms more accessible and adding to community development through job creation.

Everyday lapses in memory can be a part of learning.